REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/01/2025
Back to search
Official data from USPTO
LEAFBIO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LEAFBIO
ST13
US500000085710504Class
1, 5, 42
Filing
85710504
Registration
4969019
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
41
Latest update
06/02/2025
Trademark type
Word
Nice classes
1, 5, 42
Filing date
08/22/2012
Registration date
05/31/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/30/2022
Last transaction
06/02/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/01/2013
First use in commerce
01/01/2013
Drawing code
4
Owner type
03
Owner location
San Diego, CA
Examiner
WILKE, JOHN
Law office
L40
Current location
TMEG LAW OFFICE 104
Holders and representatives
Holders
LeafBio, Inc.
Representatives
Paul Nardulli OPTIMA LAW GROUP, APC
Technical classification
Nice Classes
Class 1Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Diagnostic reagents for scientific or research use; Diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents to monitor toxicity of drugs; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for in vitro use in biochemistryclinical chemistry and microbiology; Diagnostic reagents for scientific or research use; Laboratory chemicalsan antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; Reagent for chemical analysis; Reagents for research purposes; Reagents for scientific or medical research use; Reagents for testing the sterility of pharmaceuticals and injectable solutions; Reagents for use in scientific apparatus for chemical or biological analysis; Reagents for use in biodefense
Class 5
Pharmaceutical products for use in the treatment and prevention of cardiovascular diseases and disorderscentral nervous system and neurological diseases and disordersurological diseases and disordersviral and infectious diseasescancergastrointestinal diseases and disordersmusculoskeletal diseases and disordersmigraines and headachespainhypertensioninflammation and inflammatory diseases and disordersmetabolic diseases and disordersrespiratory and infectious diseases and disordersimmunologicalbacterialviral and fungal diseases and disorderspsychiatric diseases and disordersasthmaallergiesdiabetesobesitystrokeerectile and sexual dysfunctionsexually transmitted infections includingbut not limited toHIVHPVherpeshemolytic diseases and disorders; Pharmaceutical preparationscholesterol preparationsosteoporosis preparationsoncological preparationsdermatological preparationsurological preparationsophthalmologic preparationstissue and skin repair preparations and gynecological preparations ; Pharmaceuticalsanti-infectives; Diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; Medical diagnostic reagents; Medical diagnostic reagents and assays for testing of body fluidsincluding for microorganisms; Drug delivery agents consisting of compounds that facility delivery of a wide range of pharmaceuticals; Antibacterial pharmaceuticals; Cardiovascular pharmaceuticals; Contraceptive foamsspongespreparations; Oral contraceptives; Pharmaceutical products for use in biodefense
Class 42
Pharmaceutical research and development; research and development of pharmaceutical preparations for the treatment and prevention of cardiovascular diseases and disorderscentral nervous system and neurological diseases and disordersviral and infectious diseasescancerurological diseases and disordersgastrointestinal diseases and disordersmusculoskeletal diseases and disordersmigraines and headachespainhypertensioninflammation and inflammatory diseases and disordersmetabolic diseases and disordersrespiratory and infectious diseases and disordersimmunologicalbacterialviral and fungal diseases and disorderspsychiatric diseases and disordersasthmaallergiesdiabetesobesitystrokeerectile and sexual dysfunctionsexually transmitted infections includingbut not limited toHIVHPVherpes and hemolytic diseases and disorders; research and development of pharmaceutical preparationscholesterol preparationsosteoporosis preparationsoncological preparationsdermatological preparationsurological preparationsophthalmologic preparationstissue and skin repair preparations and gynecological preparations ; research and development of drug delivery devices; medical and scientific researchconducting clinical trials; Consulting services in the fields of biotechnologypharmaceutical research and developmentlaboratory testingdiagnosticspharmacogenetics; Development of pharmaceutical preparations and medicines; Pharmaceutical drug development; Pharmaceutical research and development services; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto; Pharmaceutical research and development in relation to biodefense
Publications
History of USPTO decisions and trademark events.
41 publications found
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
11/30/2022
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11/30/2022
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/17/2022
E815
TEAS SECTION 8 & 15 RECEIVED
05/12/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
05/31/2016
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
04/26/2016
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/23/2016
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/16/2016
IUAF
USE AMENDMENT FILED
03/17/2016
EISU
TEAS STATEMENT OF USE RECEIVED
03/17/2016
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
09/29/2015
EX5G
SOU EXTENSION 5 GRANTED
09/27/2015
EXT5
SOU EXTENSION 5 FILED
09/09/2015
EEXT
SOU TEAS EXTENSION RECEIVED
09/09/2015
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
04/04/2015
EX4G
SOU EXTENSION 4 GRANTED
04/03/2015
EXT4
SOU EXTENSION 4 FILED
03/20/2015
EEXT
SOU TEAS EXTENSION RECEIVED
03/20/2015
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
10/02/2014
EX3G
SOU EXTENSION 3 GRANTED
10/01/2014
EXT3
SOU EXTENSION 3 FILED
09/19/2014
EEXT
SOU TEAS EXTENSION RECEIVED
09/19/2014
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/03/2014
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
04/18/2014
EX2G
SOU EXTENSION 2 GRANTED
04/17/2014
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/14/2014
EXT2
SOU EXTENSION 2 FILED
03/20/2014
EEXT
SOU TEAS EXTENSION RECEIVED
03/20/2014
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
09/26/2013
EX1G
SOU EXTENSION 1 GRANTED
09/24/2013
EXT1
SOU EXTENSION 1 FILED
09/24/2013
EEXT
SOU TEAS EXTENSION RECEIVED
09/24/2013
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
03/26/2013
PUBO
PUBLISHED FOR OPPOSITION
01/29/2013
NPUB
NOTICE OF PUBLICATION
01/09/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/17/2012
DOCK
ASSIGNED TO EXAMINER
12/15/2012
MPMK
NOTICE OF PSEUDO MARK MAILED
08/31/2012
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/30/2012
NWAP
NEW APPLICATION ENTERED
08/25/2012
Continuous trademark protection
Get notified about every new filing that threatens LEAFBIO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.